Comparative Billing Report for Breast Cancer using CA 15-3/CA 27.29 — On Demand

This OnDemand Medicare webinar is focused on exploring Comparative Billing Reports (CBRs) related to breast cancer testing using tumor markers CA 15-3 and CA 27.29. This session will help healthcare providers understand Medicare’s coverage policies, appropriate use of these immunoassay tests for monitoring breast cancer, and how to interpret CBR data to identify billing trends and ensure compliance.